OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Blue-Ribbon Poly A+ RNA and Total RNA
Rapid-Screen Arrayed cDNA Library Panels
cDNA Libraries
Molecular Tools
PrecisionShuttle ORF Vector System


OriGene cDNA clones in recent publications
Activation of the Ca2+-sensing receptor increases renal claudin-14 expression and urinary Ca2+ excretion Am J Physiol Renal Physiol, Mar 2013; 304: F761 - F769. [Cldn14]

An SRF/miR-1 axis regulates NCX1 and Annexin A5 protein levels in the normal and failing heart Cardiovasc Res, Mar 2013; 10.1093/cvr/cvt042. [JunD]

Betaglycan Alters NFB-TGFß2 Cross Talk to Reduce Survival of Human Granulosa Tumor Cells Mol. Endocrinol., Mar 2013; 27: 466 - 479. [SMAD3]

Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression Carcinogenesis, Mar 2013; 34: 550 - 559. [cathepsin B]

View All Citations >>

SURE-RACE CDNA 5' END DISCOVERY PANELS

Traditional cDNA libraries frequently yield clones which are incomplete and where sequences representing mRNA 5' ends are missing. RACE technology, a PCR-based approach for rapid amplification of cDNA ends, has been particularly useful for completing the missing portions of cDNA clones and yielding full-length sequences of expressed gene regions.

To expand the utility of the RACE technology, OriGene has developed Sure-RACE cDNA 5 End Discovery Panels - PCR-ready RACE panel that allow simultaneous 5' end analysis of transcripts from 24 individual human tissues or 24 mouse tissues and developmental stages. Sure-RACE cDNA 5 End Discovery Panels contain double-stranded cDNAs that have been arrayed in multi-well plates.

  • Broad spectrum of tissues: scan 24 individual human or mouse tissues
  • High sensitivity: detect rare transcripts
  • Simultaneous analysis of alternatively spliced transcripts and alternate RNA start-sites

Sure-RACE Discovery Panels are designed with the recognition that an increasing number of genes have been identified that utilize alternate RNA start-sites resulting from tissue-specific or developmental stage-specific transcriptional promoters. In addition, an increasing number of genes have also been found to utilize alternate 5 exons, sometimes resulting in protein products with different N-terminal amino acid sequences.

 Terms of Use

Display Products Download Product Fact Sheet
First-strand cDNA Synthesis Kit
Inc 5000 Healthcare Company Copyright © 2013 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title